Skip to main content

Erythropoietin in Continuous Ambulatory Peritoneal Dialysis Patients, 1990 Benefits of the Subcutaneous Route in the First U. S. Experience

  • Chapter
Ambulatory Peritoneal Dialysis
  • 50 Accesses

Abstract

We have routinely used erythropoietin (EPO) by subcutaneous route of administration in all patients entering our chronic peritoneal dialysis (PD) program since its inception in March 1989. The criteria for use of the medication was an anemia with hematocrit (HCT) values less than 30 vol. %. One patient entering the program had been on EPO during the predialysis phase of his illness, while some others had received EPO during prior treatment with hemodialysis (HD). In all cases the route of administration was subcutaneous. This preferential use of subcutaneous EPO was based on our favorable experience with EPO in predialysis patients with severe anemia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Mäher JF, Hirszel P. in: Nolph KD (ed.): üInternational, Eighth Annual CAPD Conference, 1985, pp. 267–296.

    Google Scholar 

  2. Teehan BP, Schleifer CR, Sigler MH, Gilgor GS. Perit Dial Bull 1985; 5: 152–156.

    Google Scholar 

  3. Di Paolo N, Buoncristiani U, Gaggliotti E, Capotondo L, Di Mia M. Peril Dial Bull 1986; 6: 44–45.

    Google Scholar 

  4. Mistry CD, Gokal R, Mallick NP. in: Maher JF, Winchester JF (eds.): Frontiers in Peritoneal Dialysis, New York: Field Rich, 1986, pp. 241–248.

    Google Scholar 

  5. Khanna R, Mactier R, Twardowski ZJ, Nolph KD. Perit Dial Bull 1986; 6: 113–121.

    Google Scholar 

  6. Maiorca R, Cantaluppi A, Cancarini GC, et al. Lancet 1983; 2: 642–644.

    Article  PubMed  CAS  Google Scholar 

  7. Cantaluppi A, Scalamogna A, Castelnovo C, Graziani G. Perit Dial Bull 1986; 6: 58–61.

    Google Scholar 

  8. Junor BJR, Briggs JD, Forwell MA, Dobbie JW, Henderson IA. Perit Dial Bull 1985; 5: 101–104.

    Google Scholar 

  9. Branner FP, Brynger H, Chantler C, et al. Proc Eur Dial Transplant Assoc 1979; 16: 4.

    Google Scholar 

  10. Steinberg SM, Cutler SJ, Novak JW, Nolph KD. The National Institutes of Health CAPD Patient Registry Report, Bethesda, MD: National Institutes of Health, January 1986.

    Google Scholar 

  11. Broyer M, Brunner FP, Brynger H, et al. Proc Eur Dial Transplant Assoc 1983; 20: 3. 17

    Google Scholar 

  12. Drukker, W, History of Hemodialysis, in: Maher JF (ed.): Replacement of Renal Function by Dialysis ( ed. 3 ), The Hague: Martinus Nijhoff, 1989, p. 35.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Plenum Publishing Corporation

About this chapter

Cite this chapter

Stern, L., Vernocchi, L., Monstroski, L., Appel, G.B. (1990). Erythropoietin in Continuous Ambulatory Peritoneal Dialysis Patients, 1990 Benefits of the Subcutaneous Route in the First U. S. Experience. In: Avram, M.M., et al. Ambulatory Peritoneal Dialysis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9555-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-9555-7_2

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4615-9557-1

  • Online ISBN: 978-1-4615-9555-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics